New Jersey resident Jeff Borghoff, a patient in Biogen's failed clinical trial for Alzheimer's, was left heartbroken when he heard the news the experimental treatment was unlikely to work.
New Jersey resident Jeff Borghoff, a patient in Biogen's failed clinical trial for Alzheimer's, was left heartbroken when he heard the news the experimental treatment was unlikely to work.